Posts by apAdmin
SS-31: Research Overview
SS-31 (also known as Szeto-Schiller peptide 31, or elamipretide) is a synthetic tetrapeptide developed by Hazel Szeto and Peter Schille...
MOTS-C: Research Overview
MOTS-C (Mitochondrial Open Reading Frame of the 12S rRNA-c) is a mitochondria-derived peptide (MDP) encoded within the mitochondrial ge...
Tesamorelin: Research Overview
Tesamorelin is a synthetic analogue of growth hormone-releasing hormone (GHRH), consisting of the complete 44-amino-acid sequence of en...
Semax: Research Overview
Semax is a synthetic heptapeptide analogue of the adrenocorticotropic hormone (ACTH) fragment 4–7, developed in Russia during the 1980s...
KPV: Research Overview
KPV is a tripeptide consisting of lysine, proline, and valine — the C-terminal fragment of alpha-melanocyte stimulating hormone (α-MSH)...
Selank: Research Overview
Selank is a synthetic hexapeptide developed by the Institute of Molecular Genetics of the Russian Academy of Sciences. Structurally, it...
BPC-157: Research Overview
BPC-157, short for Body Protection Compound-157, is a synthetic peptide derived from a naturally occurring protein found in human gastr...
Peptides Under Investigation in Women’s Hormonal and Aging Research: A Perimenopausal Context
Researchers are investigating peptides including Epitalon, GHK-Cu, MOTS-c, and Tesamorelin in the context of women's hormonal aging and perimenopausal biology.
Peptides Studied for Dopamine and Reward Pathway Support in GLP-1 Research Contexts
GLP-1 agonists modulate dopamine pathways in research models. Scientists are exploring adjunct peptides — Semax, Selank, and BPC-157 — in parallel research contexts.
Retatrutide Research Overview: The Triple Agonist Peptide Researchers Are Watching
Retatrutide is a GLP-3 triple agonist peptide showing 24% weight reduction in Phase 2 trials. Research overview: mechanism, data, and what scientists are tracking.